![Alimera Sciences, Inc. logo](/logos/ALIM.webp)
Alimera Sciences, Inc.
NASDAQ:ALIM
Overview | Financials
Company Name | Alimera Sciences, Inc. |
Symbol | ALIM |
Currency | USD |
Price | 5.56 |
Market Cap | 302,376,152 |
Dividend Yield | 0% |
52-week-range | 2.606 - 5.65 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Richard S. Eiswirth Jr. |
Website | https://alimerasciences.com |
An error occurred while fetching data.
About Alimera Sciences, Inc.
Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of ophthalmic pharmaceuticals in the United States and internationally. It offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and lead to
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD